Msi (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Msi, is an opioid analgesic presented as a sterile injectable solution for intrathecal, intravenous, and subcutaneous use. It is employed to manage severe acute pain, chronic pain, and cancer‑related pain in adult patients.

GNH USA supplies Msi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from comprehensive regulatory support and timely delivery across multiple continents.

Morphine Sulfate is an opioid analgesic used to treat pain conditions that involve the central nervous system.

- Severe acute pain: provides rapid relief of intense pain following surgery or trauma. - Chronic pain: helps manage persistent pain that does not respond to non‑opioid therapies. - Cancer pain: alleviates moderate to severe pain associated with malignant disease.

Morphine Sulfate may cause a range of adverse reactions, varying from mild and transient symptoms to potentially life‑threatening events, and patients should be monitored for these effects.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Constipation: reduced bowel movements leading to hard stools. - Drowsiness: increased sleepiness affecting alertness. - Dry mouth: reduced salivation causing oral discomfort. - Sweating: excessive perspiration, especially at higher doses.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can become life‑threatening, requiring immediate intervention. - Severe hypotension: marked drop in blood pressure, may cause dizziness or fainting. - Anaphylactic reaction: sudden severe allergic response with rash, swelling, and airway compromise.

When using Morphine Sulfate, clinicians should observe several precautions to minimize risks and ensure safe administration.

- Assess patient history: evaluate prior opioid use, respiratory disorders, and allergy status. - Monitor respiratory function: check breathing rate and oxygen saturation regularly. - Adjust dose in renal/hepatic impairment: reduce dosage or increase interval as needed. - Avoid concurrent CNS depressants: limit use of benzodiazepines or alcohol. - Educate patient and caregivers: provide information on proper use, storage, and signs of overdose. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Morphine Sulfate can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - MAO inhibitors: risk of severe serotonin syndrome and respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression. - CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced analgesic effect. - Diuretics: may enhance hypotensive response. - Anticholinergics: may worsen constipation.